Beverly Barton Rogers

Beverly Barton Rogers

Auto-generated profile, based on publicly available information

Beverly Barton Rogers

Department of Pathology, Children’s Healthcare of Atlanta, Atlanta, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
MHMatthew C. Hiemenz
Matthew C. Hiemenz
DODejerianne G. Ostrow
Dejerianne G. Ostrow
TBTracy M. Busse
Tracy M. Busse
JBJonathan Buckley
Jonathan Buckley
DMDennis T. Maglinte
Dennis T. Maglinte
JBJaclyn A. Biegel
Jaclyn A. Biegel

1 March 2003 in Pediatric and Developmental Pathology
Verified
Journal Article
Closed access
PDF file
MBMarie-Anne Bründler
Marie-Anne Bründler
NRNorberto Rodriguez-Baez
Norberto Rodriguez-Baez
RJRon Jaffe
Ron Jaffe
AWArthur G. Weinberg
Arthur G. Weinberg
BRBeverly Barton Rogers
Beverly Barton Rogers
Three children, two with liver transplants and one with acquired human immunodeficiency virus (HIV) infection, presented with hepatitis accompanied by elevated gamma glutamyl transpeptidase. Biopsies revealed cholangiohepatitis caused by adenovirus infection. There was a progressive loss of interlobular bile ducts in two of the patients. In one patient, infection of the biliary tree was marked by a necrotizing cholangitis, with adenoviral inclusions noted in the biliary epithelium. In each patient, there was evidence of adenovirus gastrointestinal infection. This is the first report of adenoviral infection of the biliary tree in humans. It is hypothesized that adenovirus cholangiohepatitis occurs as a result of ascending infection from the gastrointestinal tract to the biliary tree.

1 May 2003 in Pediatric and Developmental Pathology
Verified
Journal Article
Closed access
PDF file
RDRakheja Dinesh
Rakheja Dinesh
Golder North WilsonGolder North Wilson
Golder North Wilson
BRBeverly B. Rogers
Beverly B. Rogers
We describe a female infant with morphologic features of Rutledge multiple-congenital-anomaly syndrome (RM-CAS) and biochemical features of Smith-Lemli-Opitz syndrome (SLOS). She had microcephaly with hypoplastic cerebral frontal lobes and cerebellum, agenesis of the splenium of corpus callosum, abnormal facies including hypertelorism with bilateral inner epicanthal folds, a broad nasal bridge with slightly anteverted nares and patent choanae, low set ears and complex conchal formation, high-arched palate and thick maxillary alveolar ridges, and micrognathia. Her chest was broad, genitalia were ambiguous, and uterus was bicornuate. Skeletal abnormalities included a hypoplastic appendicular skeleton, post-axial hexadactyly of the right hand and the left foot, syndactyly of bilateral 2nd–3rd toes and left 5th–6th toes, right talipes varus and left talipes valgus, and fused L5–S1 vertebrae. Congenital heart disease consisted of hypoplastic left heart, coronary sinus agenesis, ostium secundum and ostium primum defects, and a thickened septum primum. The lungs were hypolobated and the kidneys manifested oligopapillary hypoplasia. Total colonic Hirschsprung disease was noted microscopically. Analysis of liver tissue taken at postmortem examination revealed the ratio of 7-dehydrocholesterol and cholesterol to be 143 (expected, 0.28 ± 0.28). Although initially described as a distinct syndrome, RMCAS was merged with the severe form of SLOS, because of significantly overlapping features [Online Mendelian Inheritance in Man (OMIM) #268670]. The biochemical data showing an excess of 7-dehydrocholesterol and low cholesterol in the liver tissue of our case supports this viewpoint.

25 June 2025 in Virchows Archiv
Verified
Journal Article
Open access
PDF file
TKT. Yee Khong
T. Yee Khong
CKC.J. Kim
C.J. Kim
BRB.B. Rogers
B.B. Rogers
Villitis of unknown etiology (VUE) can be categorized as distal, proximal, or basal, depending on the type of chorionic villi involved. Either terminal or mature intermediate villi are affected in the distal type, while stem villi are affected in the proximal type. The Amsterdam Placental Workshop Group Consensus Statement did not amplify on the definition of basal VUE. We review the literature to explore the entity, focusing on the terminology, inflammatory infiltrate, involved structures, prevalence, and clinical significance. The prevalence of the lesion, variously defined, in placentas with differing indications for pathological examination and which could include cases with concurrent intraparenchymal VUE ranges from 6.6 to 28.3% of VUE; however, the prevalence of VUE confined only to basal and parabasal villi could be as low as 3%. We propose that the villi that are inflamed must be clearly identified as anchoring or anchored villi; that the preferred term is basal chronic villitis; and that it is diagnosed when chorionic inflammation of anchoring villi, or of villi anchored within the basal plate is seen. No studies have looked specifically at the clinical significance of basal villitis; associations with donor oocyte IVF pregnancies, fetal growth restriction, hypertensive disorders of pregnancy, pre-eclampsia, and morbidly adherent placenta have been reported by some but not confirmed by others. VUE should continue to be reported as intraparenchymal, basal, or mixed until such time that the accumulated experience of the clinical correlates suggests there is no merit in doing so.

2 December 2020 in American Journal of Hematology
Verified
Journal Article
Open access
PDF file
PGPaul E. George
Paul E. George
CSClaire L. Stokes
Claire L. Stokes
LBLeda C. Bassit
Leda C. Bassit
ACAnn Chahroudi
Ann Chahroudi
JFJanet Figueroa
Janet Figueroa
WLWilbur Lam
Wilbur Lam
Click on the article title to read more.

1 June 2021 in Data in Brief
Verified
Journal Article
Open access
CICristina Interiano
Cristina Interiano
SMSheicho Muze
Sheicho Muze
BTBrian Turner
Brian Turner
MGMark Gonzalez
Mark Gonzalez
BRBeverly Rogers
Beverly Rogers
VLVan Leung-Pineda
Van Leung-Pineda
SARS-CoV-2 infection in children does not seem to follow the same pattern as in adults. Limited information is published on the level of antibody production and the duration of antibody response in children with COVID-19. Moreover, it is unknown if all children have a similar immune response to the infection, or if there are age dependent differences. In this data, we look at the IgM and IgG levels and duration of two age groups infected by the SARS-CoV-2 virus. Residual laboratory specimens from pediatric patients positive for SARS-CoV-2 infection were tested for IgM and IgG against SARS-CoV-2 using an automated Abbott ARCHITECT i1000. We tested 181 specimens from 41 patients with a positive molecular result. Data was grouped either as time after nucleic acid amplification test (NAAT) or time after symptom onset. Patient samples were divided into 2 age groups: 0 to 11 years old and 12 to 19 years old. The assays detect IgM against the spike protein and IgG against the nucleocapsid protein.